Selected research
Market Outlook & Growth Opportunities
Global Legal Surrogacy Market Outlook and Growth Opportunities 2026
Market perspective
The global Legal Surrogacy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Legal Surrogacy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Legal Surrogacy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Legal Surrogacy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Legal Surrogacy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Legal Surrogacy market include New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions and Cardone & Associates Reproductive Medicine & Infertility, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Legal Surrogacy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Legal Surrogacy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Legal Surrogacy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Legal Surrogacy market.
Legal Surrogacy Segment by Company
New Hope Fertility Center
IVI-RMA Global
Scanfert AVA Clinic
Bourn Hall Fertility Clinic
Nova IVI Fertility
Ovation Fertility
Bangkok IVF Center
Extraordinary Conceptions
Cardone & Associates Reproductive Medicine & Infertility
Max Healthcare
Growing Generations
Circle Surrogacy
Morpheus Life Sciences
Legal Surrogacy Segment by Type
Intrauterine Insemination (IUI)
In-vitro Fertilization (IVF)
Others
Legal Surrogacy Segment by Application
Below 35 Years
35-45 Years
Over 45 Years
Legal Surrogacy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Legal Surrogacy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Legal Surrogacy key companies, revenue, market share, and recent developments.
3. To split the Legal Surrogacy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Legal Surrogacy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Legal Surrogacy significant trends, drivers, influence factors in global and regions.
6. To analyze Legal Surrogacy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Legal Surrogacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Legal Surrogacy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Legal Surrogacy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Legal Surrogacy industry.
Chapter 3: Detailed analysis of Legal Surrogacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Legal Surrogacy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Legal Surrogacy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Intrauterine Insemination (IUI)
- In-vitro Fertilization (IVF)
- Others
Applications
- Below 35 Years
- 35-45 Years
- Over 45 Years
Companies covered
- New Hope Fertility Center
- IVI-RMA Global
- Scanfert AVA Clinic
- Bourn Hall Fertility Clinic
- Nova IVI Fertility
- Ovation Fertility
- Bangkok IVF Center
- Extraordinary Conceptions
- Cardone & Associates Reproductive Medicine & Infertility
- Max Healthcare
- Growing Generations
- Circle Surrogacy
- Morpheus Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Legal Surrogacy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Legal Surrogacy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Legal Surrogacy Market Dynamics
- 2.1 Legal Surrogacy Industry Trends
- 2.2 Legal Surrogacy Industry Drivers
- 2.3 Legal Surrogacy Industry Opportunities and Challenges
- 2.4 Legal Surrogacy Industry Restraints
3 Legal Surrogacy Market by Company
- 3.1 Global Legal Surrogacy Company Revenue Ranking in 2025
- 3.2 Global Legal Surrogacy Revenue by Company (2021-2026)
- 3.3 Global Legal Surrogacy Company Ranking (2024-2026)
- 3.4 Global Legal Surrogacy Company Manufacturing Base and Headquarters
- 3.5 Global Legal Surrogacy Company Product Type and Application
- 3.6 Global Legal Surrogacy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Legal Surrogacy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Legal Surrogacy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Legal Surrogacy Market by Type
- 4.1 Legal Surrogacy Type Introduction
- 4.1.1 Intrauterine Insemination (IUI)
- 4.1.2 In-vitro Fertilization (IVF)
- 4.1.3 Others
- 4.2 Global Legal Surrogacy Sales Value by Type
- 4.2.1 Global Legal Surrogacy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Legal Surrogacy Sales Value by Type (2021-2032)
- 4.2.3 Global Legal Surrogacy Sales Value Share by Type (2021-2032)
5 Legal Surrogacy Market by Application
- 5.1 Legal Surrogacy Application Introduction
- 5.1.1 Below 35 Years
- 5.1.2 35-45 Years
- 5.1.3 Over 45 Years
- 5.2 Global Legal Surrogacy Sales Value by Application
- 5.2.1 Global Legal Surrogacy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Legal Surrogacy Sales Value by Application (2021-2032)
- 5.2.3 Global Legal Surrogacy Sales Value Share by Application (2021-2032)
6 Legal Surrogacy Regional Value Analysis
- 6.1 Global Legal Surrogacy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Legal Surrogacy Sales Value by Region (2021-2032)
- 6.2.1 Global Legal Surrogacy Sales Value by Region: 2021-2026
- 6.2.2 Global Legal Surrogacy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Legal Surrogacy Sales Value (2021-2032)
- 6.3.2 North America Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Legal Surrogacy Sales Value (2021-2032)
- 6.4.2 Europe Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Legal Surrogacy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Legal Surrogacy Sales Value (2021-2032)
- 6.6.2 South America Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Legal Surrogacy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Legal Surrogacy Sales Value Share by Country, 2025 VS 2032
7 Legal Surrogacy Country-level Value Analysis
- 7.1 Global Legal Surrogacy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Legal Surrogacy Sales Value by Country (2021-2032)
- 7.2.1 Global Legal Surrogacy Sales Value by Country (2021-2026)
- 7.2.2 Global Legal Surrogacy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.7.2 France Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.14.2 China Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.17.2 India Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Legal Surrogacy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Legal Surrogacy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Legal Surrogacy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 New Hope Fertility Center
- 8.1.1 New Hope Fertility Center Company Information
- 8.1.2 New Hope Fertility Center Business Overview
- 8.1.3 New Hope Fertility Center Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.1.4 New Hope Fertility Center Legal Surrogacy Product Portfolio
- 8.1.5 New Hope Fertility Center Recent Developments
- 8.2 IVI-RMA Global
- 8.2.1 IVI-RMA Global Company Information
- 8.2.2 IVI-RMA Global Business Overview
- 8.2.3 IVI-RMA Global Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.2.4 IVI-RMA Global Legal Surrogacy Product Portfolio
- 8.2.5 IVI-RMA Global Recent Developments
- 8.3 Scanfert AVA Clinic
- 8.3.1 Scanfert AVA Clinic Company Information
- 8.3.2 Scanfert AVA Clinic Business Overview
- 8.3.3 Scanfert AVA Clinic Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.3.4 Scanfert AVA Clinic Legal Surrogacy Product Portfolio
- 8.3.5 Scanfert AVA Clinic Recent Developments
- 8.4 Bourn Hall Fertility Clinic
- 8.4.1 Bourn Hall Fertility Clinic Company Information
- 8.4.2 Bourn Hall Fertility Clinic Business Overview
- 8.4.3 Bourn Hall Fertility Clinic Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.4.4 Bourn Hall Fertility Clinic Legal Surrogacy Product Portfolio
- 8.4.5 Bourn Hall Fertility Clinic Recent Developments
- 8.5 Nova IVI Fertility
- 8.5.1 Nova IVI Fertility Company Information
- 8.5.2 Nova IVI Fertility Business Overview
- 8.5.3 Nova IVI Fertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.5.4 Nova IVI Fertility Legal Surrogacy Product Portfolio
- 8.5.5 Nova IVI Fertility Recent Developments
- 8.6 Ovation Fertility
- 8.6.1 Ovation Fertility Company Information
- 8.6.2 Ovation Fertility Business Overview
- 8.6.3 Ovation Fertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.6.4 Ovation Fertility Legal Surrogacy Product Portfolio
- 8.6.5 Ovation Fertility Recent Developments
- 8.7 Bangkok IVF Center
- 8.7.1 Bangkok IVF Center Company Information
- 8.7.2 Bangkok IVF Center Business Overview
- 8.7.3 Bangkok IVF Center Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.7.4 Bangkok IVF Center Legal Surrogacy Product Portfolio
- 8.7.5 Bangkok IVF Center Recent Developments
- 8.8 Extraordinary Conceptions
- 8.8.1 Extraordinary Conceptions Company Information
- 8.8.2 Extraordinary Conceptions Business Overview
- 8.8.3 Extraordinary Conceptions Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.8.4 Extraordinary Conceptions Legal Surrogacy Product Portfolio
- 8.8.5 Extraordinary Conceptions Recent Developments
- 8.9 Cardone & Associates Reproductive Medicine & Infertility
- 8.9.1 Cardone & Associates Reproductive Medicine & Infertility Company Information
- 8.9.2 Cardone & Associates Reproductive Medicine & Infertility Business Overview
- 8.9.3 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.9.4 Cardone & Associates Reproductive Medicine & Infertility Legal Surrogacy Product Portfolio
- 8.9.5 Cardone & Associates Reproductive Medicine & Infertility Recent Developments
- 8.10 Max Healthcare
- 8.10.1 Max Healthcare Company Information
- 8.10.2 Max Healthcare Business Overview
- 8.10.3 Max Healthcare Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.10.4 Max Healthcare Legal Surrogacy Product Portfolio
- 8.10.5 Max Healthcare Recent Developments
- 8.11 Growing Generations
- 8.11.1 Growing Generations Company Information
- 8.11.2 Growing Generations Business Overview
- 8.11.3 Growing Generations Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.11.4 Growing Generations Legal Surrogacy Product Portfolio
- 8.11.5 Growing Generations Recent Developments
- 8.12 Circle Surrogacy
- 8.12.1 Circle Surrogacy Company Information
- 8.12.2 Circle Surrogacy Business Overview
- 8.12.3 Circle Surrogacy Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.12.4 Circle Surrogacy Legal Surrogacy Product Portfolio
- 8.12.5 Circle Surrogacy Recent Developments
- 8.13 Morpheus Life Sciences
- 8.13.1 Morpheus Life Sciences Company Information
- 8.13.2 Morpheus Life Sciences Business Overview
- 8.13.3 Morpheus Life Sciences Legal Surrogacy Revenue and Gross Margin (2021-2026)
- 8.13.4 Morpheus Life Sciences Legal Surrogacy Product Portfolio
- 8.13.5 Morpheus Life Sciences Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst